Q2 2021 Holdings
Filed 2021-08-16 | 33 holdings | $333.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $216.0M | 9,817,190 | 64.8% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $58.7M | 2,000,000 | 17.6% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $50.7M | 1,240,000 | 15.2% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $5.7M | 1,643,426 | 1.7% |
| Taiwan Semiconductor MFG LTD(TSM) | SPONSORED ADS | 874039100 | $811.6K | 6,754,120 | 0.2% |
| Paypal Hldgs Inc(PYPL) | COM | 70450Y103 | $702.3K | 2,409,413 | 0.2% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $344.8K | 9,861,089 | 0.1% |
| CM Life Sciences Inc | COM CL A | 18978W109 | $59.3K | 4,229,704 | 0.0% |
| Lyell Immunopharma Inc | COM | 55083R104 | $56.8K | 3,500,000 | 0.0% |
| Ironsource LTD | CL A ORD SHS | M5R75Y101 | $52.5K | 5,000,000 | 0.0% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $51.6K | 2,625,153 | 0.0% |
| Elliott Opportunity II Corp | UNIT 99/99/9999 | G30092129 | $49.6K | 4,950,000 | 0.0% |
| Ftac Hera Acquisition Corp | CLASS A ORD SHS | G3728Y103 | $48.8K | 5,000,000 | 0.0% |
| CM Life Sciences III Inc | CLASS A COM | 125841106 | $41.3K | 4,000,000 | 0.0% |
| Khosla Ventures Acqut Co III | COM CL A | 482506102 | $39.5K | 4,000,000 | 0.0% |
| Compute Health Acquisitin Co | COM CL A | 204833107 | $39.3K | 4,000,000 | 0.0% |
| Khosla Ventures Acqustn Co I | COM CL A | 482505104 | $34.8K | 3,500,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $30.5K | 993,402 | 0.0% |
| Revolution Healthcar AQ Corp | CLASS A COM | 76155Y108 | $29.5K | 3,000,000 | 0.0% |
| Aurora Acquisition Corp | UNIT 03/02/2026 | G0698L111 | $28.1K | 2,700,000 | 0.0% |
| SVF Investment Corp | UNIT 12/20/2025 | G8601L110 | $22.4K | 2,200,000 | 0.0% |
| SVF Investment Corp 3 | CL A SHS | G8601N108 | $19.9K | 2,000,000 | 0.0% |
| Ftac Athena Acquisition Corp | CL A SHS | G37283101 | $19.7K | 2,000,000 | 0.0% |
| Khosla Ventures Acquisition | CL A | 482504107 | $14.8K | 1,500,000 | 0.0% |
| SVF Investment Corp 2 | CL A SHS | G8601M100 | $10.0K | 1,000,000 | 0.0% |
| CM Life Sciences II Inc | UNIT 02/25/2028 | 125842203 | $5.5K | 411,151 | 0.0% |
| Bridgetown 2 Holdings LTD | CL A | G1355V103 | $5.1K | 500,000 | 0.0% |
| CM Life Sciences III IncCall | *W EXP 04/30/202 | 125841114 | $2.1K | 800,000 | 0.0% |
| Ftac Hera Acquisition CorpCall | *W EXP 02/28/202 | G3728Y111 | $1.7K | 1,250,000 | 0.0% |
| Compute Health Acquisitin CoCall | *W EXP 01/25/202 | 204833115 | $1.5K | 1,000,000 | 0.0% |
| Pioneer Merger CorpCall | *W EXP 01/07/202 | G7S24C111 | $1.5K | 916,666 | 0.0% |
| Revolution Healthcar AQ CorpCall | *W EXP 12/31/202 | 76155Y116 | $846 | 600,000 | 0.0% |
| Ftac Athena Acquisition CorpCall | *W EXP 03/01/202 | G37283119 | $750 | 500,000 | 0.0% |